BioCentury
ARTICLE | Clinical News

Sulfasim: Filed IND for a Phase I/II trial

March 13, 1995 8:00 AM UTC

Cortech Inc. (CRTQ), Denver Product: Sulfasim, blocker of immune system recognition of the antimicrobial sulfamethoxazole, used in AIDS to prevent or treat Pneumocystis carenii pneumonia Indication: P...